Role of fructose in obesity, a new perspective
HQ Team October 20, 2023: A new research paper suggests that fructose, a type of sugar, maybe a significant driver of obesity. While.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team October 20, 2023: A new research paper suggests that fructose, a type of sugar, maybe a significant driver of obesity. While.
HQ Team October 20, 2023: More than half a billion people worldwide are living with diabetes, and this number is expected to rise..
HQ Team October 19, 2023: Experiments conducted on young adult rats have established a link between Alzheimer’s and gut microbiota, according to a.
HQ Team October 18, 2023: Hyloris Pharmaceuticals SA, Liège, Belgium-based biopharma company, announced the US Food and Drug Administration has approved its post-operative.
HQ Team October 16, 2023: Danish pharmaceutical company, Novo Nordisk, announced it was buying a hypertension drug, still in trials, from Singapore-based KBP.
HQ Team October 16, 2023: Germany’s BioNTech announced its partner Pfizer Inc.’s write-offs for inventory and other charges related to the Covid-19 Comirnaty.
HQ Team October 16, 2023: India’s Immunoactive Cell Therapy Ltd., has got a marketing authorisation from the drug regulator for a therapy to.
By Dr K. Leelamoni October 16, 2023: Sheela, 19, a student studying medicine in India’s southern city of Thiruvananthapuram, was bitten by a.
HQ Team October 13, 2023: Conflict-torn Gaza is running out of food, water, electricity and critical supplies as an Israeli blockade prevents aid.
HQ Team October 13, 2023: Eli Lilly and Company announced its experimental drug for treating severe Crohn’s disease met secondary targets in efficacy.